Try our Advanced Search for more refined results

FTC Challenges Asthma Product Patents Listed With FDA

By Kelly Lienhard (November 7, 2023, 7:57 PM EST) -- The Federal Trade Commission challenged over 100 patents related to asthma treatment held by 10 major pharmaceutical companies including AstraZeneca, Teva and GlaxoSmithKline on Tuesday, claiming that the drug manufacturers listed inaccurate patents in the U.S. Food and Drug Administration's Orange Book....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!